CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $392,144
- in 8 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-22 | Hatfield Jeffrey S. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2018-02-22 | Hughes Thomas E. See Remarks | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2018-02-22 | Allen Patricia L Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2018-01-03 | Daniel Thomas O Director | Grant or award | +8,687 | $5.18 | $45K | 19,452 |
| 2018-01-03 | LAMATTINA JOHN L Director | Grant or award | +9,169 | $5.18 | $47K | 20,532 |
| 2018-01-03 | Barrett Peter Director | Grant or award · Stock Option (Right to Buy) | +17,627 | 17,627 | ||
| 2018-01-03 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +8,509 | 8,509 | ||
| 2018-01-03 | McDonough Cameron Geoffrey Director | Grant or award · Stock Option (Right to Buy) | +9,725 | 9,725 | ||
| 2018-01-03 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +9,421 | 9,421 | ||
| 2017-12-29 | Hatfield Jeffrey S. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,100,000 | 1,100,000 | ||
| 2017-10-13 | Heller Frances K Director | Purchase | +10,000 | $3.90 | $39K | 47,961 |
| 2017-10-09 | Hatfield Jeffrey S. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +550,000 | 550,000 | ||
| 2017-10-09 | Hughes Thomas E. See Remarks | Grant or award · Employee Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2017-07-11 | KIM DENNIS D Chief Medical Officer | Purchase | +10,000 | $3.39 | $34K | 21,443 |
| 2017-06-21 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2017-06-21 | McDonough Cameron Geoffrey Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2017-06-21 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2017-06-21 | LAMATTINA JOHN L Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2017-06-21 | THOMAS FRANK E Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2017-06-21 | Barrett Peter Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 |
Page 9 of 15 · 296 trades